| Literature DB >> 27625702 |
Edoardo Errichiello1, Francesca Novara1, Anna Cremante2, Annapia Verri2, Jessica Galli3, Elisa Fazzi3, Daniela Bellotti4, Laura Losa5, Mariangela Cisternino5, Orsetta Zuffardi1.
Abstract
BACKGROUND: Partial deletion of chromosome 21q is a very rare chromosomal abnormality associated with highly variable phenotypes, such as facial dysmorphic features, heart defects, seizures, psychomotor delay, and severe to mild intellectual disability, depending on the location and size of deletions. So far, three broad deletion regions of 21q have been correlated with the clinical phenotype.Entities:
Keywords: Array Comparative Genomic Hybridization (array-CGH); BTG3 (BTG family; Behavioral disorders; DNA Copy Number Variations (CNVs); GRIK1 (glutamate receptor; Intellectual Disability (ID); Ionotropic; Kainate 1); Member 3); Partial 21q monosomy; RBM11 (RNA binding motif protein 11)
Year: 2016 PMID: 27625702 PMCID: PMC5020505 DOI: 10.1186/s13039-016-0230-3
Source DB: PubMed Journal: Mol Cytogenet ISSN: 1755-8166 Impact factor: 2.009
Fig. 1Clinical features (a), G-banded karyotypes (b) and array-CGH profiles (c) of patients with chromosome 21q deletions. Chromosomes 21 shown in the red boxes (b) are enlarged in respect to the original karyograms. Parents of patient 4 denied permission to publish pictures
Summary of patients harboring 21q deletions overlapping with patients 1–5 and corresponding clinical features
| Patient | Age at diagnosis (yr) | Phenotype (main features) | Chromosomal coordinates of deletion (hg38) | Size (Mb) | Genes (protein coding) | Inheritance | Pathogenicity |
|---|---|---|---|---|---|---|---|
| Patients 1-2-3 (present study) | 53 (#1), 20 (#2), 18 (#3) | Obsessive-compulsive disorders, impaired social interactions, aggressiveness, delayed speech and language development, mild facial dismorphisms | chr21:21754822-32380347 | 10.63 | 112 (52) | Paternal | Pathogenic |
| Patient 4 (present study) | 6 | Intellectual disability, global movement impairment, dysmorphic features, dyslexia, dyscalculia, primary amenorrhoea, obesity, pituitary microadenoma | chr21:13048294-27532614 | 14.48 | 117 (21) | De novo | Pathogenic |
| Patient 5 (present study) | 4 | Intellectual disability, mild psychomotor delay, speech delay, hypotonia, DCD (a), Duane syndrome type 3, bilateral iris/choroidal coloboma | chr21:14000146-27785985 | 13.79 | 112 (23) | De novo | Pathogenic |
| chr16:28813473-29030738 | 0.22 | 35 (24) | Maternal | Pathogenic | |||
| Case 1 (Petit et al., 2015) [ | 7 | Behavioural/psychiatric abnormality, attention deficit, impaired social interactions, frustration, aggressiveness, delayed speech and language development | chr21:21062316-24943120 | 3.88 | 16 (1) | Maternal | Unknown |
| Case 2 (Petit et al., 2015) [ | 9 | Global developmental delay, speech delay, hyperactivity, impairment of social interactions | chr21:15619936-23525918 | 7.91 | 50 (9) | Paternal (mosaicism) | Unknown |
| Case 3 (Petit et al., 2015) [ | 5 | Global developmental delay, hypotonia, constipation, impaired social interactions | chr21:16079383-24575840 | 8.50 | 48 (7) | Unknown | Unknown |
| KKI patient 3 - cohort A (Roberson et al., 2011) | 6 | Speech delay, mild/moderate mental retardation, dysmorfic features, hypotonia, GERD (b), eczema, dermatographism | chr21:16814345-33232252 | 16.42 | 159 (69) | De novo | Unknown |
| chr4:65863868-66006319 | 0.14 | 0 | Maternal | Unlikely pathogenic | |||
| chr14:22625231–22795061 (c) | 0.17 (c) | 2 (2) | Paternal | Unlikely pathogenic | |||
| GM00137 - cohort B (Roberson et al., 2011) [ | 6 | Severe psychomotor retardation, microcephaly, dysmorphic features, bilateral iris coloboma | chr21:13403408-28392024 | 14.99 | 124 (23) | Unknown | Unknown |
| chr4:68917-11238519 | 11.17 | 229 (122) | Unknown | Unknown | |||
| GM06918 - cohort B (Roberson et al., 2011) [ | 9 | Mental retardation, dysmorphic features | chr21:14981488-32298829 | 17.32 | 156 (61) | De novo | Unknown |
| Haldeman-Englert et al., 2010 [ | 2 | Poor social interactions, speech delay, mild dysmorphic features, PDD-NOS (d) | chr21:21085454-29813876 | 8.73 | 62 (18) | De novo | Pathogenic |
| Case 31 (Lyle et al., 2009) [ | Unknown | Dysmorphic features, short stature, mental retardation, synbrachydactily | chr21:12965809-30890916 | 17.93 | 180 (56) | Unknown | Unknown |
| Case 32 (Lyle et al., 2009) [ | Unknown | Dysmorphic features, short stature, mental retardation, microcephaly, clinodactily, hypotonia | chr21:12965809-30218169 | 17.26 | 145 (31) | Unknown | Unknown |
| Case 33 (Lyle et al., 2009) [ | Unknown | Mental retardation | chr21:12965809-26199556 | 13.23 | 108 (15) | Unknown | Unknown |
| Hannachi et al., 2011 [ | 26 | Moderate mental retardation, minor brain malformations, craniofacial dysmorphic features, azoospermia, diffuse cerebral atrophy | chr21:13603505-29194209 | 15.59 | 130 (23) | Maternal | Likely pathogenic |
| Decipher#285024 | 2 | Ataxia, intellectual disability, poor speech, lower limb spasticity, speech articulation difficulties | chr21:13224687-27912651 | 14.69 | 124 (23) | Unknown | Pathogenic |
| Decipher#285691 | 10 | Cognitive impairment, generalized myoclonic seizures, microcephaly, asymmetry of the ears | chr21:13045202-33522318 | 20.48 | 217 (76) | Unknown | Pathogenic |
| ECARUCA#4777 | 16 | Mental retardation, seizures/abnormal EEG (e), short stature, prominent maxilla, dislocation of hip, atrial septum defect | chr21:14166659-20412272 | 6.25 | 66 (13) | De novo | Unknown |
| chr21:43013575-46699983 | 3.69 | 116 (67) | De novo | Unknown | |||
| ECARUCA#4841 | 9 | Mental retardation, seizures/abnormal EEG (e), facial dysmorphisms | chr21:15292766-19704615 | 4.41 | 31 (6) | De novo | Unknown |
(a) DCD developmental coordination disorder (b) GERD gastroesophageal reflux disease (c)duplication (d) PDD-NOS pervasive developmental disorder not otherwise specified (e) EEG Electroencephalogram
Fig. 2Comparison of 21q deletion cases with mild (purple) and moderate/severe (green) phenotypes (behavioral disorders and intellectual disability, respectively). The protein-coding genes of 21q region are mainly grouped into two main clusters. The proximal cluster includes genes more likely involved in intellectual disability (BTG3 and RBM11), whereas the distal cluster mainly contains genes related to behavioral disorders, such as GRIK1 (almost completely deleted in the case reported by Haldeman-Englert et al., [13]). KKI-3, GM00137, and ECARUCA#4777 cases also had rearrangements involving chromosomes other than 21 (as reported in Table 1) that might contribute to the clinical severity
Fig. 3Subsetting of the great 21q region 1 described by Lyle and colleagues in 2009 into two smaller subregions. Deletions in the subregion 1, from the centromere to ~ 21 Mb (including BTG3 and RBM11), are mainly associated with severe intellectual disability, whereas deletions of the subregion 2, until approximately 32 Mb (including GRIK1), are more tightly associated with milder neurobehavioral disorders, such as poor social interactions. Patients with a deletion overpassing the two subregions clinically manifested the most severe phenotype